Previous Close | 9.80 |
Open | 9.68 |
Bid | 9.47 x 100 |
Ask | 9.53 x 100 |
Day's Range | 9.46 - 9.82 |
52 Week Range | 6.07 - 17.02 |
Volume | |
Avg. Volume | 906,691 |
Market Cap | 554.808M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RA Capital increased its stake in biopharmaceutical firm ARS. Bain Capital lowered its stake in pharmaceutical firm Nuvalent.
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript March 7, 2024 Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.8, expectations were $-0.92. PHAT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Phathom […]
Q4 2023 Phathom Pharmaceuticals Inc Earnings Call